Clinical Trials Directory

Trials / Suspended

SuspendedNCT05731206

Hypoallergenicity of a Hydrolyzed Protein Infant Formula

Study to Assess Hypoallergenicity of a Hydrolysed Protein Formula in Children With Confirmed Cow's Milk Allergy

Status
Suspended
Phase
N/A
Study type
Interventional
Enrollment
29 (estimated)
Sponsor
Nutricia Research · Industry
Sex
All
Age
0 Days – 3 Years
Healthy volunteers
Not accepted

Summary

Study to demonstrate hypoallergenicity of a hydrolysed protein infant formula in a population of children with confirmed cow's milk allergy.

Detailed description

The study consists of a double-blind, placebo-controlled food challenge, followed by a single arm open challenge.

Conditions

Interventions

TypeNameDescription
OTHERHydrolyzed protein infant formulaHydrolyzed protein infant formula
OTHERcommercially available hypoallergenic infant formulacommercially available hypoallergenic infant formula

Timeline

Start date
2024-07-31
Primary completion
2026-12-31
Completion
2027-03-31
First posted
2023-02-16
Last updated
2024-05-08

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05731206. Inclusion in this directory is not an endorsement.

Hypoallergenicity of a Hydrolyzed Protein Infant Formula (NCT05731206) · Clinical Trials Directory